[1]
G. A. Ramos, “THE ROLE OF ECULUZIMAB IN THE PROGNOSIS OF SHIGA TOXIN- ASSOCIATED HEMOLYTIC-UREMIC SYNDROME IN CHILDREN: A LITERATURE REVIEW”, EIC, pp. 97–106, Nov. 2025, Accessed: Jun. 02, 2026. [Online]. Available: https://periodicos.newsciencepubl.com/editoraimpacto/article/view/10222